1. Home
  2. KIDS vs PRTC Comparison

KIDS vs PRTC Comparison

Compare KIDS & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OrthoPediatrics Corp.

KIDS

OrthoPediatrics Corp.

HOLD

Current Price

$16.92

Market Cap

401.2M

Sector

Health Care

ML Signal

HOLD

Logo PureTech Health plc

PRTC

PureTech Health plc

HOLD

Current Price

$17.81

Market Cap

400.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KIDS
PRTC
Founded
2007
2015
Country
United States
United States
Employees
N/A
90
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
401.2M
400.2M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
KIDS
PRTC
Price
$16.92
$17.81
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
$24.67
N/A
AVG Volume (30 Days)
146.6K
3.0K
Earning Date
05-06-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$98,049,000.00
N/A
Revenue This Year
$14.07
N/A
Revenue Next Year
$11.85
N/A
P/E Ratio
N/A
$8.09
Revenue Growth
37.95
N/A
52 Week Low
$14.91
$14.50
52 Week High
$23.70
$19.92

Technical Indicators

Market Signals
Indicator
KIDS
PRTC
Relative Strength Index (RSI) 54.16 67.33
Support Level $16.74 $16.60
Resistance Level $19.15 $18.12
Average True Range (ATR) 0.71 0.36
MACD 0.09 0.29
Stochastic Oscillator 94.66 91.19

Price Performance

Historical Comparison
KIDS
PRTC

About KIDS OrthoPediatrics Corp.

OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: